Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation: Studies in CETP transgenic mice and human genetic CETP deficiency

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1045-1052

  Oliveira, Helena C F ^a   Ma, Limei ^a   Milne, Ross ^b   Marcovina, Santica M ^c   Inazu, Akihiro ^d   Mabuchi, Hiroshi ^d   Tall, Alan R ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cholesterol esterification rate; Cholesteryl ester transfer protein; Reverse cholesterol transport; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; MESSENGER RNA; MONOCLONAL ANTIBODY; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE;

ADULT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION; GENETIC DISORDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TRANSGENIC MOUSE;

EID: 0030947631     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1045     Document Type: Article

References (53)

1. Tall AR. Plasma lipid transfer proteins. Anna Rev Biochem. 1995;64:235-257.
2. Glomset JA. The plasma lecithimcholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
3. Whitlock ME, Swenson TL, Ramakrishnan R, Leonard MT, Marcel YL, Milne RW, Tall AR. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J din Invest. 1989;84:129-137.
4. Jiang X-C, Masucci-Magoulas L, Mar J, Lin M, Walsh A, Breslow JL, Tall AR. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein: mechanism to explain accumulation of lipoprotein B particles. J Biol Chem. 1993:268:27406-27412.
5. Groener J.E, van Gent T, van Toi A. Effect of lipid transfer protein on plasma llpids, apolipoproteins and metabolism of high density lipoprotein cholesteryl ester in the rat. Biochim Biophys Acta. 1989;1002:93-100.
6. Fielding CJ, Fielding PE. Evidence for a lipoprotein carrier in human plasma catalyzing sterol efflux from cultured fibroblasts and its relationship to lecilhinxholesterol acyltransferase. Proc Natl Acad Sci USA. 1981:78:3911-3914.
7. Ohta T, Nakamura R, Ikeda Y, Shinohara M, Miyazaki A, Horiuchi S, Matsuda I. Differential effect of subspecies of lipoprotein containing apolipoprotein AI on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithinxholesterol acyltransferase. Biochim Biophys Acta. 1992;1165:119-128.
8. Chajek T, Aron L, Fielding CJ. Interaction of Iecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in the transport of cholesteryl ester into sphingomyelin liposomes. Biochemistry. 1980;19:3673-3677.
9. Yen FT, Deckelbaum RJ, Mann CJ, Marcel YL, Milne RW, Tall AR. Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody: effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest. 1989;83:2018-2024.
10. Agellon LB, Walsh A, Hayek T, Moulin P, Jiang X-C, Shelanski SA, Breslow JL, Tall AR. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem. 1991;266:10796-10801.
11. Koizumi J, Mabuchi H, Yoshimura A, Michishita I, Takeda M, Itoh H, Sakai Y, Sakai T, Ueda K, Takeda R. Deficiency of serum cholesteryl ester transfer protein in patients with familial hyperalphalipoproteinaemia. Atherosclerosis. 1985;58:175-186.
12. Ohta T, Nakamura R, Takata K, Saito Y, Yamashita S, Horiuchi S, Matsuda I. Structural and functional differences of subspecies of apoA-I-containing lipoprotein in patients with plasma cholesteryl ester transfer protein deficiency. J Lipid Res. 1995:36:696-704.
13. Inazu A, Jiang X-C, Haraki T, Yagi K, Kamon N, Koizumi N, Mabuchi H, Takeda R, Takata K, Moriyama Y, Doi M, Tall AR. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest. 1994;94:1872-1882.
14. Funke H, Wiebusch H, Fuer L, Muntoni S, Schulte H, Assman G. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation. 1994;90(suppl I):I-241. Abstract.
15. Gordon DJ, Rifkind BM. High density lipoproteins: the clinical implications of recent studies. N Engl J Med. 1989:321:1311-1316.
16. Zhong S, Sharp D, Grove J, Bruce C, Yano K, Curb D, Tall AR. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. In press.
17. Hayek T, Massucci-Magoulas L, Jiang X, Walsh A, Rubin E, Breslow JL, Tall AR. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest. 1995;96:2071-2074.
18. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, Tall AR. Molecular basis of lipid transfer protein deficiency in a family with increased high density lipoproteins. Nature. 1989;342:448-451.
19. Takahashi K, Jiang X-C, Sakai N, Yamashita S, Hirano K, Bujo H, Yamazaki H, Kusunoki J, Miura T, Kussie P, Matsuzawa Y, Saito Y, Tall A. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoprotein. J Clin Invest. 1993;92:2060-2064.
20. Jiang X-C, Agellon LB, Walsh A, Breslow JL, Tall AR. Dietary cholesterol increases transcription of human cholesteryl ester transfer protein gene in transgenic mice: dependence on natural flanking sequences. J Clin Invest. 1992;90:1290-1295.
21. Walsh A, Azrolan N, Wang K, Marcigliano A, O'Connell A, Breslow JL. Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 30 to the gene in the promoter of the adjacent convergently transcribed apoC-III gene. J Lipid Res. 1993;34:617-624.
22. Hesler CB, Tall AR, Swenson TL, Weech PK, Marcel YL, Milne RW. Monoclonal antibodies to the Mr74000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglycéride transfer activities in human plasma. J Biol Chem. 1988;263:5020.
23. Evans GF, Bensch WR, Apelgren LD, Bailey D, Kauffman RF, Bumol TF, Zuckerman SH. Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution. J Lipid Res. 1994;35:1634-1645.
24. Chen CH, Albers JJ. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin: cholesterol acyltransferase activity. J Lipid Res. 1982;23:680-691.
25. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
26. Marcel YL, McPherson R, Hogue M, Czarnecka H, Zawadzki Z, Weech P, Whitlock M, Tall AR, Milne RW. Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipidemic subjects. J Clin Invest. 1990;85:10-17.
27. Albers JJ, Adolphson JC, Chen CH. Radioimmunoassay of human lecithin-cholesterol acyltransferase. J Clin Invest. 1981;67:141-148.
28. Tall AR, Granot E, Brocia R, Tabas I, Hesler C, Williams K, Denke M. Accelerated transfer of cholesteryl ester in dyslipidemic plasma: role of cholesteryl ester transfer protein. J Clin Invest. 1987;79: 1217-1225.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Chem. 1987;162:156-159.
30. Bailey JM, Davidson N. Methylmercury as a reversible denaturing agent for agarose gel electrophoresis. Anal Biochem. 1976;70:75-85.
31. Warden CH, Langner CA, Gordon JI, Taylor B A, McLean J W, Lusis AJ. Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin: cholesterol acyltransferase gene: evidence for expression in brain and testes as well as liver. J Biol Chem. 1989:264:21573-21581.
32. Quinet EM, Agellon LB, Kroon PA, Marcel YL, Lee YC, Whitlock ME, Tall AR. Atherogenic diet increases cholesteryl ester transfer protein (CETP) mRNA levels in rabbit liver. J Clin Invest. 1990:85:357-363.
33. Jiang X-C, Moulin P, Quinet E, Goldberg U, Yacoub LK, Agellon LB, Compton D, Schnitzer-Polokoff R, Tall AR. Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem. 1991:266:4631-4639.
34. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res. 1993:34:1255-1274.
35. Peterson J, Bengtsson-Olivercrona G, Olivercrona T. Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin. Biochim Biophys Ada. 1986:878:65-70.
36. Francone OL, Gurakar A, Fielding CJ. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J Biol Chem. 1989:264:7066-7072.
37. Yamashita S, Sprecher DL, Sakai N, Matsuzawa Y, Tarui S, Hui DY. Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects wilh plasma cholesteryl ester transfer protein deficiency. J Clin Invest. 1990;86:688-695.
38. Gaynor BJ, Sand T, Clark RW, Aiello RJ, Bamberger MJ, Moberly JB. Inhibition of cholesteryl ester transfer protein activity in hamsters alters HDL lipid composition. Atherosclerosis. 1994;110:101-109.
39. Jonas A. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Blochim BiophysActa. 1991:1084:205-220.
40. Bruce C, Davidson WS, Kussie P, Lund-Katz S, Phillips MC, Ghosh R, Tall AR. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins. J Biol Chem. 1995:270:11532-11542.
41. Massucci-Magoulas L, Plump A, Jiang X-C, Walsh A, Breslow JL, Tall AR. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor knock out mice: a novel mechanism signals changes in plasma cholesterol levels. J Clin Invest. 1996;97:1-9.
42. Yamashita S, Hirano J, Ishigami M, Arai T, Sakai S, Nasaki S, Takemura K, Matsuzawa Y, Hirano K, et al. Marked hyperalphalipoproteinemia (HALF) due to a combined reduction in cholesteryl ester transfer protein (CETP) and hepatic triglycéride lipase (HTGL) is accompanied by atherosclerotic cardiovascular diseases (ACD). Arteriosder Thromb Vase Biol. 1995:15:1849-1856.
43. Koizumi J, Inazu A, Yagi K, Koizumi I, Uno Y, Kajinami K, Miyamoto S, Moulin P, Tall AR, Mabuchi H, Takeda R. Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency. Atherosclerosis. 1991 ;90:189-196.
44. Shamburek RD, Nishiwaki M, Ishikawa T, Nakamura H, Ikewaki K, Zech LA, Rader DJ, Brewer HB Jr, Schwanz CC. Cholesteryl ester transfer protein deficiency: in vivo metabolism of free and esterified cholesterol. Circulation. 1993;88(suppl I):I-75. Abstract.
45. Ray E, Bellini F, Stoudt G, Hemperly S, Rothblat G. Influence of lecithin:cholesterol acyltransferase on cholesterol metabolism in hepatoma cells and hepatocytes. Biochim Biopliys Ada. 1980;617: 318-334.
46. Nakamura R, Ohta T, Ikeda Y, Matsuda I. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apo AIcontaining lipoproteins, a putative mechanism for foam cell formation. Arterioscler Thromb. 1993:13:1307-1316.
47. Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 1993:364:73-75.
48. Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, Tall AR, Breslow JL. Hypertriglyceridemia and cholesteryl ester transfer interact to dramatically alter high density lipoprotein levels, particle sizes and metabolism. J din Invest. 1993:92:1143-1152.
49. Castro GR, Fielding CJ Early incorporation of cell-derived cholesterol into pre-b-migrating high density lipoprotein. Biochemistry. 1988;27:25-29.
50. Smith EB, Ashall C. Compartmentalization of water in atherosclerotic lesions: changes in distribution and exclusion volumes for plasma macromolecules. Arteriosclerosis. 1984;4:21-27.
51. Rudra DN, Myant NB, Pflug JJ, Reichl D. The distribution of cholesterol and apolipoprotein AI between the lipoproteins in plasma and peripheral lymph from normal human subjects. Atherosclerosis. 1984:53:297-308.
52. Kunitake ST, Mendel CM, Hennessy LK. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res. 1992;33:1807-1816.
53. Nagasaki T, Akanuma Y. A new colorimelric method for the determination of plasma lecithin-cholesterol acyltransferase activity. Clin ChimActa. 1977:75:371-375.